Clinical Trial Update: An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin [Phase 1]

View source ↗

Summary

A Phase 1 ethno-bridging study of Pergoveris in healthy premenopausal Japanese and Caucasian participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Pergoveris (follitropin alfa and lutropin alfa)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Fertility | Phase 1 | Status: COMPLETED